These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Intravenous thrombolysis in patients with acute ischaemic stroke with history of prior ischaemic stroke within 3 months. Tsivgoulis G; Katsanos AH; Schellinger PD; Köhrmann M; Steiner T; Caso V; Palaiodimou L; Strbian D; Ahmed N; Alexandrov A; Savitz SI J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1383-1385. PubMed ID: 30995998 [No Abstract] [Full Text] [Related]
23. Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis. Wong JWP; Churilov L; Dowling R; Mitchell P; Bush S; Kanesan L; Yan B Cerebrovasc Dis; 2018; 46(5-6):193-199. PubMed ID: 30384367 [TBL] [Abstract][Full Text] [Related]
24. Cardiac monitoring in stroke units: importance of diagnosing atrial fibrillation in acute ischemic stroke. Vivanco Hidalgo RM; Rodríguez Campello A; Ois Santiago A; Cuadrado Godia E; Pont Sunyer C; Roquer J Rev Esp Cardiol; 2009 May; 62(5):564-7. PubMed ID: 19406071 [TBL] [Abstract][Full Text] [Related]
25. Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke. Marsch A; Macha K; Siedler G; Breuer L; Strasser EF; Engelhorn T; Dörfler A; Schwab S; Kallmünzer B Cerebrovasc Dis; 2019; 48(1-2):17-25. PubMed ID: 31484174 [TBL] [Abstract][Full Text] [Related]
26. Complexities of Reperfusion Therapy in Patients With Ischemic Stroke Pretreated With Direct Oral Anticoagulants: To Treat or Not, and How? Czap AL; Grotta JC JAMA Neurol; 2021 May; 78(5):517-518. PubMed ID: 33720276 [No Abstract] [Full Text] [Related]
27. Multicenter Prospective Analysis of Stroke Patients Taking Oral Anticoagulants: The PASTA Registry - Study Design and Characteristics. Suda S; Iguchi Y; Fujimoto S; Yagita Y; Kono Y; Ueda M; Todo K; Kono T; Mizunari T; Yamazaki M; Kanzawa T; Okubo S; Kondo K; Nakajima N; Inoue T; Iwanaga T; Nakajima M; Imafuku I; Shibazaki K; Mishina M; Adachi K; Nomura K; Nakajima M; Yaguchi H; Okamoto S; Osaki M; Terasawa Y; Nagao T; Kimura K J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104456. PubMed ID: 31676161 [TBL] [Abstract][Full Text] [Related]
29. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant. Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623 [TBL] [Abstract][Full Text] [Related]
30. Would you perform thrombolysis in this acute ischemic stroke patient? Ahmad A; Teoh HL; Sharma VK Arch Neurol; 2009 Mar; 66(3):410-1. PubMed ID: 19273764 [No Abstract] [Full Text] [Related]
31. Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. Purrucker JC; Wolf M; Haas K; Rizos T; Khan S; Dziewas R; Kleinschnitz C; Binder A; Gröschel K; Hennerici MG; Lobotesis K; Poli S; Seidel G; Neumann-Haefelin T; Ringleb PA; Heuschmann PU; Veltkamp R Stroke; 2016 Apr; 47(4):1127-30. PubMed ID: 26931156 [TBL] [Abstract][Full Text] [Related]
32. Reversal of Vitamin K Antagonist Therapy Before Thrombolysis for Acute Ischemic Stroke. Chausson N; Soumah D; Aghasaryan M; Altarcha T; Alecu C; Smadja D Stroke; 2018 Oct; 49(10):2526-2528. PubMed ID: 30355096 [TBL] [Abstract][Full Text] [Related]
33. Intravenous thrombolysis for acute ischemic stroke: time is prime. Ingall TJ Stroke; 2009 Jun; 40(6):2264-5. PubMed ID: 19390067 [No Abstract] [Full Text] [Related]
34. Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke. Hoyer C; Filipov A; Neumaier-Probst E; Szabo K; Ebert A; Alonso A J Thromb Thrombolysis; 2018 May; 45(4):529-535. PubMed ID: 29476304 [TBL] [Abstract][Full Text] [Related]
35. Functional Outcomes Among Patients With Acute Ischemic Stroke After Mechanical Thrombectomy With or Without Intravenous Thrombolysis-Reply. Kimura K; Otsuka T; Suzuki K JAMA; 2021 May; 325(19):2020. PubMed ID: 34003227 [No Abstract] [Full Text] [Related]
36. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K; Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811 [TBL] [Abstract][Full Text] [Related]
37. Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Chen ST; Hellkamp AS; Becker RC; Berkowitz SD; Breithardt G; Fox KAA; Hacke W; Halperin JL; Hankey GJ; Mahaffey KW; Nessel CC; Piccini JP; Singer DE; Patel MR Am J Cardiol; 2017 Nov; 120(10):1837-1840. PubMed ID: 28886856 [TBL] [Abstract][Full Text] [Related]
38. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials. Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948 [TBL] [Abstract][Full Text] [Related]